VistaGen Therapeutics (NASDAQ: VTGN) is a clinical-stage biopharmaceutical company developing new generation medicines for multiple CNS diseases and disorders with high unmet need. 

Education

Pharmaceutical

VistaGen Therapeutics

VistaGen Therapeutics' headquarters in South San Francisco, CA, United States

Shawn K. Singh

Nick Tressler

Elissa S. Cote

Ross Baker

Edith Perez

Ross A. Baker

Michelle Peters Wellington

Mark J. Ginski

Trisha Fitzmaurice

Joshua Prince

Reid Adler

Jerry Gin

Brian J. Underdown

Mary L. Rotunno

Joanne Curley

Jon S. Saxe

Ann M. Cunningham

Maurizio Fava

Gordon Keller

Thomas Laughren

Michael Liebowitz

Sanjay Mathew

Gerard Sanacora

Mark Wallace

The Leadership Team at VistaGen Therapeutics is responsible for guiding the strategic direction of the company. Comprising senior executives from key functional areas such as development operations, legal, and strategic insights, this team collaborates to drive innovation, ensure compliance, and optimize the development of new CNS therapeutics, while addressing the high unmet needs in the market. Their collective expertise shapes the company's mission to bring transformative medicines to patients.

Leadership Team

The Clinical and Medical Team at VistaGen Therapeutics is dedicated to advancing the development of new generation medicines for CNS diseases and disorders. Comprised of experts in biostatistics, global medical affairs, translational medicine, clinical research, and clinical supply chain management, the team oversees the design, implementation, and analysis of clinical trials, ensuring the seamless supply of clinical materials and maintaining robust communication with research sites to bring innovative therapies to patients with high unmet needs.

Clinical and Medical Team

The Legal and Compliance team at VistaGen Therapeutics ensures that the company adheres to all legal and regulatory requirements pertinent to its clinical-stage biopharmaceutical operations. This includes managing legal contracts, ensuring compliance with industry standards, and safeguarding intellectual property while providing strategic legal guidance to support the development of new generation CNS medicines.

Legal and Compliance

The Project Management team at VistaGen Therapeutics oversees the coordination and execution of research and development initiatives, ensures alignment with strategic objectives, and manages project timelines, budgets, and resources. This includes collaboration across departments to support the advancement of CNS disease therapies from clinical development through to regulatory submission.

Project Management

The Regulatory and Quality Affairs team at VistaGen Therapeutics is responsible for ensuring compliance with global regulatory standards and quality systems for the development of new-generation CNS medicines. They handle the submission of regulatory documents, maintain quality assurance protocols, and liaise with regulatory authorities to facilitate clinical trials and product approvals.

Regulatory and Quality Affairs

VistaGen Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Clinical and Medical Team

Legal and Compliance

Project Management

Regulatory and Quality Affairs

Offices

VistaGen Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Clinical and Medical Team

Legal and Compliance

Project Management

Regulatory and Quality Affairs

Offices

Related companies